Vivos Therapeutics (VVOS) Share-based Compensation (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Share-based Compensation of $2.6 million for Q1 2026, up 720.19% year-over-year from $317000.0 in Q1 2025, and up 2923.26% quarter-over-quarter from $86000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Share-based Compensation (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Share-based Compensation for 7 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 720.19% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (down 68.36% YoY), while the FY2025 annual figure was $2.8 million, down 20.0% from the prior year.
- Share-based Compensation rose to $2.6 million in Q1 2026 per VVOS's latest filing, from $86000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $7.5 million in Q2 2024 and bottomed at -$913000.0 in Q4 2023.
- Historically, Share-based Compensation has averaged $986647.1 across 5 years, with a median of $317000.0 in 2025.
- Annual changes were most pronounced in 2023 — Share-based Compensation plunged 217.81% — and 2024, when it soared 1775.0%.
- Vivos Therapeutics' Share-based Compensation stood at $775000.0 in 2022, then slumped by 217.81% to -$913000.0 in 2023, then surged by 110.95% to $100000.0 in 2024, then decreased by 14.0% to $86000.0 in 2025, then surged by 2923.26% to $2.6 million in 2026.
- Business Quant data shows VVOS's Share-based Compensation at $2.6 million in Q1 2026, $86000.0 in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Vivos Therapeutics | 4.97 Mn | 3.17 Mn | 2.95 Mn | 2.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.60 Mn |
| Mar 31, 2026 | 2.60 Mn |
| Dec 31, 2025 | 86,000.00 |
| Dec 31, 2025 | 86,000.00 |
| Sep 30, 2025 | 2.80 Mn |
| Sep 30, 2025 | 2.80 Mn |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 317,000.00 |
| Mar 31, 2025 | 317,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 7.50 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 293,000.00 |
| Mar 31, 2024 | 293,000.00 |
| Dec 31, 2023 | -913,000.00 |
| Dec 31, 2023 | -913,000.00 |